HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Liu, S. Articles by Chen, J.-J. PubMed PubMed Citation Articles by Liu, S. Articles by Chen, J.-J.

Deficiency of heme-regulated eIF2 kinase decreases hepcidin expression and splenic iron in HFE^–/– mice

¹ Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA
² Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA

Correspondence: Jane-Jane Chen, E25-406A, MIT, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. E-mail: j-jchen{at}mit.edu

Heme-regulated eIF2 kinase (HRI) is essential for regulating globin translation in iron deficiency and in β-thalassemia. We investigated the role of heme-regulated eIF2 kinase in hemoglobin and red blood cell production as well as in iron homeostasis in a mouse model of iron overload. We show that HRI deficiency does not significantly affect red cell parameters of hemochromatosis (HFE^–/–) mice. Importantly, heme-regulated eIF2 kinase deficiency exacerbates decreases in hepcidin expression and splenic macrophage iron in HFE^–/– mice. Furthermore, the serum level of bone morphogenic protein 2, which positively regulates hepcidin, is reduced in heme-regulated eIF2 kinase deficiency, but not in HFE deficiency.

Key words: heme-regulated eIF2 kinase, hepcidin, iron deficiency.